The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma

  1. García-Sanz, R.
  2. González-López, T.J.
  3. Vázquez, L.
  4. Hermida, G.
  5. Graciani, I.F.
  6. San Miguel, J.F.
Journal:
European Journal of Haematology

ISSN: 0902-4441,  1600-0609

Year of publication: 2010

Volume: 84

Issue: 3

Pages: 266-270

Type: Article

DOI: 10.1111/J.1600-0609.2009.01375.X GOOGLE SCHOLAR